Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020
Eli Lilly broke ground on a $5 billion manufacturing facility in Goochland County, Virginia, its first fully integrated site producing both active pharmaceutical ingredients and finished medicines. The Richmond site will make antibody-drug conjugates for next-generation cancer treatments and is part of Lilly's more than $50 billion U.S. manufacturing build-out spanning 10 new sites since 2020.
Key figures
- New jobs
- 650
- Construction jobs
- 1800
- Site investment usd
- 5000000000
- Us sites since 2020
- 10
- Total us expansion commitment
- $50 billion
- Workforce training commitment
- 40000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.